Fig. 9.
Effect of EPO on differentiation of AML1-ETO–expressing cells cultured for 4 weeks in IL-3, IL-6, and SCF alone.
(A-D) Immunophenotypic profile of GFP+CD13−AML1-ETO–expressing cells labeled with antibodies to one other determinate as indicated. Data indicate mean ± 1 SD (n = 3). Error bars represent 1 SD. (E) Morphology of day 55 AML1-ETO–expressing cells cultured with EPO since day 29 (representative Wright-Giemsa staining of a cytocentrifuge preparation). Original magnification × 400.